Evaluation of the efficacy of XELOX(L-OHP: 100mg/m2)+Bevacizumab for patient with metastatic or recurrent Colorectal Cancer as first-line chemotherapy
收藏NIAID Data Ecosystem2026-03-07 收录
官方服务：
资源简介：
Interventions: Capecitabine plus oxaliplatin(L-OHP: 100mg/m2) with bevacizumab Primary outcome(s): Response Rate Study Design: Single arm Non-randomized
创建时间：
2012-04-15
